Carsten Brunn, Ph.D.

Chairman

Equibles does not estimate personal net worth.

Get an email with a short summary when Cartesian Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get RNAC alerts

About Carsten Brunn, Ph.D.

Carsten Brunn, Ph.D. is recorded as Chairman at Cartesian Therapeutics, Inc. (RNAC) since October 29, 2025. Cartesian Therapeutics, Inc. reported in an 8-K filed October 30, 2025 that Carsten Brunn, Ph.D. was appointed Chairman of the Board, effective October 29, 2025. Cartesian Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cartesian Therapeutics, Inc. includes Carsten Brunn (CEO and Board Member), Blaine Davis (CFO and Chief Accounting Officer), Kevin Tan (CFO) and 7 others.

“the Board appointed Carsten Brunn, Ph.D., as Chairman of the Board”

Cartesian Therapeutics, Inc. Form 8-K, filed October 30, 2025 · Read the filing

Affiliation history

Cartesian Therapeutics, Inc. (RNAC)
Chairman

SEC 8-K

Current
2025-10-29–present

Company network

Cartesian Therapeutics, Inc.

RNAC

Current role

Biotechnology · Healthcare

Chairman

2025-10-29–present

Leadership on record at Cartesian Therapeutics, Inc.

Carsten Brunn CEO, Board Member
Blaine Davis CFO, Chief Accounting Officer
Kevin Tan CFO
Metin Kurtoglu COO
Metin Kurtoglu, M.D., Ph.D. COO
June Seymour Chief Accounting Officer
Adrian Bot Board Member
Adrian Bot, M.D., Ph.D. Board Member
Carrie S. Cox Board Member
Kemal Malik Board Member

Recent activity

Executive change Appointed: Chairman of the Board Cartesian Therapeutics, Inc. (RNAC)
2025-10-29